Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase

[Display omitted] The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase (RdRp) plays a central role in virus replication. NS5B has no functional equivalent in mammalian cells and, as a consequence, is an attractive target for selective inhibition. This Letter describes the discovery of a new...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2016-09, Vol.26 (18), p.4536-4541
Hauptverfasser: Pierra Rouvière, Claire, Amador, Agnès, Badaroux, Eric, Convard, Thierry, Da Costa, Daniel, Dukhan, David, Griffe, Ludovic, Griffon, Jean-François, LaColla, Massimiliano, Leroy, Frédéric, Liuzzi, Michel, Loi, Anna Giulia, McCarville, Joe, Mascia, Valeria, Milhau, Julien, Onidi, Loredana, Paparin, Jean-Laurent, Rahali, Rachid, Sais, Efisio, Seifer, Maria, Surleraux, Dominique, Standring, David, Dousson, Cyril
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4541
container_issue 18
container_start_page 4536
container_title Bioorganic & medicinal chemistry letters
container_volume 26
creator Pierra Rouvière, Claire
Amador, Agnès
Badaroux, Eric
Convard, Thierry
Da Costa, Daniel
Dukhan, David
Griffe, Ludovic
Griffon, Jean-François
LaColla, Massimiliano
Leroy, Frédéric
Liuzzi, Michel
Loi, Anna Giulia
McCarville, Joe
Mascia, Valeria
Milhau, Julien
Onidi, Loredana
Paparin, Jean-Laurent
Rahali, Rachid
Sais, Efisio
Seifer, Maria
Surleraux, Dominique
Standring, David
Dousson, Cyril
description [Display omitted] The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase (RdRp) plays a central role in virus replication. NS5B has no functional equivalent in mammalian cells and, as a consequence, is an attractive target for selective inhibition. This Letter describes the discovery of a new family of HCV NS5B non-nucleoside inhibitors, based on the bioisosterism between amide and phosphonamidate functions. As part of this program, SAR in this new series led to the identification of IDX17119, a potent non-nucleoside inhibitor, active on the genotypes 1b, 2a, 3a and 4a. The structure and binding domain of IDX17119 were confirmed by X-ray co-crystallization study.
doi_str_mv 10.1016/j.bmcl.2016.01.042
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1837303085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X16300427</els_id><sourcerecordid>1814135547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-4658327eb2600ed7da57bddf039ec043eeb1e69fb420ba2b1c4f99faa630520f3</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhiMEokvhD3BAPnLJMv5IspG4wKpQpAoOBcTN8sek9SqxF9tZKb-FP4ujLRwRB2t8eOaZ0bxV9ZLClgJt3xy2ejLjlpX_FugWBHtUbahoRc0FNI-rDfQt1Lte_LionqV0AKAChHhaXbCuYdALtql-3S4-32NyiYSBHENGn4nylugYlCV36ENejs6ocVyIMtmdkHy-bd6T6_134oOv_WxGDMlZJM7fO-1yiIlo563zdyQHUuzlzZMmNkzKeVJUIWWMzpDkMhK2Tl6pk4tqLDuMy4RRJXxePRnUmPDFQ72svn24-rq_rm--fPy0f3dTG77rcy3aZsdZh5q1AGg7q5pOWzsA79GA4IiaYtsPWjDQimlqxND3g1Ith3KGgV9Wr8_eYww_Z0xZTi4ZHEflMcxJ0h3vOHDYNf-BUkF504iuoOyMmhhSijjIY3STioukINf85EGu-ck1PwlUlvxK06sH_6wntH9b_gRWgLdnAMtBTg6jTMahN2hdRJOlDe5f_t9ipK5W</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1814135547</pqid></control><display><type>article</type><title>Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Pierra Rouvière, Claire ; Amador, Agnès ; Badaroux, Eric ; Convard, Thierry ; Da Costa, Daniel ; Dukhan, David ; Griffe, Ludovic ; Griffon, Jean-François ; LaColla, Massimiliano ; Leroy, Frédéric ; Liuzzi, Michel ; Loi, Anna Giulia ; McCarville, Joe ; Mascia, Valeria ; Milhau, Julien ; Onidi, Loredana ; Paparin, Jean-Laurent ; Rahali, Rachid ; Sais, Efisio ; Seifer, Maria ; Surleraux, Dominique ; Standring, David ; Dousson, Cyril</creator><creatorcontrib>Pierra Rouvière, Claire ; Amador, Agnès ; Badaroux, Eric ; Convard, Thierry ; Da Costa, Daniel ; Dukhan, David ; Griffe, Ludovic ; Griffon, Jean-François ; LaColla, Massimiliano ; Leroy, Frédéric ; Liuzzi, Michel ; Loi, Anna Giulia ; McCarville, Joe ; Mascia, Valeria ; Milhau, Julien ; Onidi, Loredana ; Paparin, Jean-Laurent ; Rahali, Rachid ; Sais, Efisio ; Seifer, Maria ; Surleraux, Dominique ; Standring, David ; Dousson, Cyril</creatorcontrib><description>[Display omitted] The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase (RdRp) plays a central role in virus replication. NS5B has no functional equivalent in mammalian cells and, as a consequence, is an attractive target for selective inhibition. This Letter describes the discovery of a new family of HCV NS5B non-nucleoside inhibitors, based on the bioisosterism between amide and phosphonamidate functions. As part of this program, SAR in this new series led to the identification of IDX17119, a potent non-nucleoside inhibitor, active on the genotypes 1b, 2a, 3a and 4a. The structure and binding domain of IDX17119 were confirmed by X-ray co-crystallization study.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2016.01.042</identifier><identifier>PMID: 27520942</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Allosteric inhibitors ; Allosteric Site ; Amide bioisostere ; Antiviral Agents - chemistry ; Antiviral Agents - metabolism ; Antiviral Agents - pharmacology ; Crystallography, X-Ray ; Direct-acting antivirals ; Genotype ; Hepacivirus - drug effects ; Hepatitis C virus ; NS5B non-nucleoside inhibitors ; Polymerase inhibitors ; Structure-Activity Relationship ; Viral Nonstructural Proteins - antagonists &amp; inhibitors ; Viral Nonstructural Proteins - metabolism</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2016-09, Vol.26 (18), p.4536-4541</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-4658327eb2600ed7da57bddf039ec043eeb1e69fb420ba2b1c4f99faa630520f3</citedby><cites>FETCH-LOGICAL-c389t-4658327eb2600ed7da57bddf039ec043eeb1e69fb420ba2b1c4f99faa630520f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X16300427$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27520942$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pierra Rouvière, Claire</creatorcontrib><creatorcontrib>Amador, Agnès</creatorcontrib><creatorcontrib>Badaroux, Eric</creatorcontrib><creatorcontrib>Convard, Thierry</creatorcontrib><creatorcontrib>Da Costa, Daniel</creatorcontrib><creatorcontrib>Dukhan, David</creatorcontrib><creatorcontrib>Griffe, Ludovic</creatorcontrib><creatorcontrib>Griffon, Jean-François</creatorcontrib><creatorcontrib>LaColla, Massimiliano</creatorcontrib><creatorcontrib>Leroy, Frédéric</creatorcontrib><creatorcontrib>Liuzzi, Michel</creatorcontrib><creatorcontrib>Loi, Anna Giulia</creatorcontrib><creatorcontrib>McCarville, Joe</creatorcontrib><creatorcontrib>Mascia, Valeria</creatorcontrib><creatorcontrib>Milhau, Julien</creatorcontrib><creatorcontrib>Onidi, Loredana</creatorcontrib><creatorcontrib>Paparin, Jean-Laurent</creatorcontrib><creatorcontrib>Rahali, Rachid</creatorcontrib><creatorcontrib>Sais, Efisio</creatorcontrib><creatorcontrib>Seifer, Maria</creatorcontrib><creatorcontrib>Surleraux, Dominique</creatorcontrib><creatorcontrib>Standring, David</creatorcontrib><creatorcontrib>Dousson, Cyril</creatorcontrib><title>Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>[Display omitted] The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase (RdRp) plays a central role in virus replication. NS5B has no functional equivalent in mammalian cells and, as a consequence, is an attractive target for selective inhibition. This Letter describes the discovery of a new family of HCV NS5B non-nucleoside inhibitors, based on the bioisosterism between amide and phosphonamidate functions. As part of this program, SAR in this new series led to the identification of IDX17119, a potent non-nucleoside inhibitor, active on the genotypes 1b, 2a, 3a and 4a. The structure and binding domain of IDX17119 were confirmed by X-ray co-crystallization study.</description><subject>Allosteric inhibitors</subject><subject>Allosteric Site</subject><subject>Amide bioisostere</subject><subject>Antiviral Agents - chemistry</subject><subject>Antiviral Agents - metabolism</subject><subject>Antiviral Agents - pharmacology</subject><subject>Crystallography, X-Ray</subject><subject>Direct-acting antivirals</subject><subject>Genotype</subject><subject>Hepacivirus - drug effects</subject><subject>Hepatitis C virus</subject><subject>NS5B non-nucleoside inhibitors</subject><subject>Polymerase inhibitors</subject><subject>Structure-Activity Relationship</subject><subject>Viral Nonstructural Proteins - antagonists &amp; inhibitors</subject><subject>Viral Nonstructural Proteins - metabolism</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1v1DAQhiMEokvhD3BAPnLJMv5IspG4wKpQpAoOBcTN8sek9SqxF9tZKb-FP4ujLRwRB2t8eOaZ0bxV9ZLClgJt3xy2ejLjlpX_FugWBHtUbahoRc0FNI-rDfQt1Lte_LionqV0AKAChHhaXbCuYdALtql-3S4-32NyiYSBHENGn4nylugYlCV36ENejs6ocVyIMtmdkHy-bd6T6_134oOv_WxGDMlZJM7fO-1yiIlo563zdyQHUuzlzZMmNkzKeVJUIWWMzpDkMhK2Tl6pk4tqLDuMy4RRJXxePRnUmPDFQ72svn24-rq_rm--fPy0f3dTG77rcy3aZsdZh5q1AGg7q5pOWzsA79GA4IiaYtsPWjDQimlqxND3g1Ith3KGgV9Wr8_eYww_Z0xZTi4ZHEflMcxJ0h3vOHDYNf-BUkF504iuoOyMmhhSijjIY3STioukINf85EGu-ck1PwlUlvxK06sH_6wntH9b_gRWgLdnAMtBTg6jTMahN2hdRJOlDe5f_t9ipK5W</recordid><startdate>20160915</startdate><enddate>20160915</enddate><creator>Pierra Rouvière, Claire</creator><creator>Amador, Agnès</creator><creator>Badaroux, Eric</creator><creator>Convard, Thierry</creator><creator>Da Costa, Daniel</creator><creator>Dukhan, David</creator><creator>Griffe, Ludovic</creator><creator>Griffon, Jean-François</creator><creator>LaColla, Massimiliano</creator><creator>Leroy, Frédéric</creator><creator>Liuzzi, Michel</creator><creator>Loi, Anna Giulia</creator><creator>McCarville, Joe</creator><creator>Mascia, Valeria</creator><creator>Milhau, Julien</creator><creator>Onidi, Loredana</creator><creator>Paparin, Jean-Laurent</creator><creator>Rahali, Rachid</creator><creator>Sais, Efisio</creator><creator>Seifer, Maria</creator><creator>Surleraux, Dominique</creator><creator>Standring, David</creator><creator>Dousson, Cyril</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope></search><sort><creationdate>20160915</creationdate><title>Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase</title><author>Pierra Rouvière, Claire ; Amador, Agnès ; Badaroux, Eric ; Convard, Thierry ; Da Costa, Daniel ; Dukhan, David ; Griffe, Ludovic ; Griffon, Jean-François ; LaColla, Massimiliano ; Leroy, Frédéric ; Liuzzi, Michel ; Loi, Anna Giulia ; McCarville, Joe ; Mascia, Valeria ; Milhau, Julien ; Onidi, Loredana ; Paparin, Jean-Laurent ; Rahali, Rachid ; Sais, Efisio ; Seifer, Maria ; Surleraux, Dominique ; Standring, David ; Dousson, Cyril</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-4658327eb2600ed7da57bddf039ec043eeb1e69fb420ba2b1c4f99faa630520f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Allosteric inhibitors</topic><topic>Allosteric Site</topic><topic>Amide bioisostere</topic><topic>Antiviral Agents - chemistry</topic><topic>Antiviral Agents - metabolism</topic><topic>Antiviral Agents - pharmacology</topic><topic>Crystallography, X-Ray</topic><topic>Direct-acting antivirals</topic><topic>Genotype</topic><topic>Hepacivirus - drug effects</topic><topic>Hepatitis C virus</topic><topic>NS5B non-nucleoside inhibitors</topic><topic>Polymerase inhibitors</topic><topic>Structure-Activity Relationship</topic><topic>Viral Nonstructural Proteins - antagonists &amp; inhibitors</topic><topic>Viral Nonstructural Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pierra Rouvière, Claire</creatorcontrib><creatorcontrib>Amador, Agnès</creatorcontrib><creatorcontrib>Badaroux, Eric</creatorcontrib><creatorcontrib>Convard, Thierry</creatorcontrib><creatorcontrib>Da Costa, Daniel</creatorcontrib><creatorcontrib>Dukhan, David</creatorcontrib><creatorcontrib>Griffe, Ludovic</creatorcontrib><creatorcontrib>Griffon, Jean-François</creatorcontrib><creatorcontrib>LaColla, Massimiliano</creatorcontrib><creatorcontrib>Leroy, Frédéric</creatorcontrib><creatorcontrib>Liuzzi, Michel</creatorcontrib><creatorcontrib>Loi, Anna Giulia</creatorcontrib><creatorcontrib>McCarville, Joe</creatorcontrib><creatorcontrib>Mascia, Valeria</creatorcontrib><creatorcontrib>Milhau, Julien</creatorcontrib><creatorcontrib>Onidi, Loredana</creatorcontrib><creatorcontrib>Paparin, Jean-Laurent</creatorcontrib><creatorcontrib>Rahali, Rachid</creatorcontrib><creatorcontrib>Sais, Efisio</creatorcontrib><creatorcontrib>Seifer, Maria</creatorcontrib><creatorcontrib>Surleraux, Dominique</creatorcontrib><creatorcontrib>Standring, David</creatorcontrib><creatorcontrib>Dousson, Cyril</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pierra Rouvière, Claire</au><au>Amador, Agnès</au><au>Badaroux, Eric</au><au>Convard, Thierry</au><au>Da Costa, Daniel</au><au>Dukhan, David</au><au>Griffe, Ludovic</au><au>Griffon, Jean-François</au><au>LaColla, Massimiliano</au><au>Leroy, Frédéric</au><au>Liuzzi, Michel</au><au>Loi, Anna Giulia</au><au>McCarville, Joe</au><au>Mascia, Valeria</au><au>Milhau, Julien</au><au>Onidi, Loredana</au><au>Paparin, Jean-Laurent</au><au>Rahali, Rachid</au><au>Sais, Efisio</au><au>Seifer, Maria</au><au>Surleraux, Dominique</au><au>Standring, David</au><au>Dousson, Cyril</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2016-09-15</date><risdate>2016</risdate><volume>26</volume><issue>18</issue><spage>4536</spage><epage>4541</epage><pages>4536-4541</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>[Display omitted] The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase (RdRp) plays a central role in virus replication. NS5B has no functional equivalent in mammalian cells and, as a consequence, is an attractive target for selective inhibition. This Letter describes the discovery of a new family of HCV NS5B non-nucleoside inhibitors, based on the bioisosterism between amide and phosphonamidate functions. As part of this program, SAR in this new series led to the identification of IDX17119, a potent non-nucleoside inhibitor, active on the genotypes 1b, 2a, 3a and 4a. The structure and binding domain of IDX17119 were confirmed by X-ray co-crystallization study.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27520942</pmid><doi>10.1016/j.bmcl.2016.01.042</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2016-09, Vol.26 (18), p.4536-4541
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_1837303085
source MEDLINE; Elsevier ScienceDirect Journals
subjects Allosteric inhibitors
Allosteric Site
Amide bioisostere
Antiviral Agents - chemistry
Antiviral Agents - metabolism
Antiviral Agents - pharmacology
Crystallography, X-Ray
Direct-acting antivirals
Genotype
Hepacivirus - drug effects
Hepatitis C virus
NS5B non-nucleoside inhibitors
Polymerase inhibitors
Structure-Activity Relationship
Viral Nonstructural Proteins - antagonists & inhibitors
Viral Nonstructural Proteins - metabolism
title Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T03%3A55%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%20potent%20and%20broad%20genotypically%20active%20NS5B%20HCV%20non-nucleoside%20inhibitors%20binding%20to%20the%20thumb%20domain%20allosteric%20site%202%20of%20the%20viral%20polymerase&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Pierra%20Rouvi%C3%A8re,%20Claire&rft.date=2016-09-15&rft.volume=26&rft.issue=18&rft.spage=4536&rft.epage=4541&rft.pages=4536-4541&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2016.01.042&rft_dat=%3Cproquest_cross%3E1814135547%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1814135547&rft_id=info:pmid/27520942&rft_els_id=S0960894X16300427&rfr_iscdi=true